Covered recipient · General Payments record
JEREMY R HUNT
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2022–2024
$1,332.61
- Reported across 83 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $516.04 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $200.69 | 21 |
| Novo Nordisk AS | $106.02 | 5 |
| Indivior Inc. | $81.83 | 3 |
| Lilly USA, LLC | $42.08 | 2 |
| Acerta Pharma LLC | $30.83 | 2 |
| PFIZER INC. | $20.82 | 1 |
| Exact Sciences Corporation | $17.92 | 1 |
| Braeburn Inc. | $15.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.83 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107373529 | CMS |
| ABBVIE INC. | $15.68 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107373531 | CMS |
| ABBVIE INC. | $3.93 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107373533 | CMS |
| ABBVIE INC. | $8.18 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107373535 | CMS |
| ABBVIE INC. | $12.01 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107373537 | CMS |
| ABBVIE INC. | $4.46 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107373539 | CMS |
| ABBVIE INC. | $19.97 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107373541 | CMS |
| ABBVIE INC. | $7.57 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107373543 | CMS |
| ABBVIE INC. | $9.03 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107373545 | CMS |
| ABBVIE INC. | $14.18 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107373547 | CMS |
| ABBVIE INC. | $6.78 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107373549 | CMS |
| ABBVIE INC. | $17.59 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107373551 | CMS |
| ABBVIE INC. | $8.27 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107373553 | CMS |
| ABBVIE INC. | $2.61 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107373555 | CMS |
| ABBVIE INC. | $11.07 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107373557 | CMS |
| ABBVIE INC. | $6.67 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107373559 | CMS |
| ABBVIE INC. | $3.32 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107373561 | CMS |
| ABBVIE INC. | $3.54 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107373563 | CMS |
| ABBVIE INC. | $5.49 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107373565 | CMS |
| ABBVIE INC. | $17.83 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107373567 | CMS |
| ABBVIE INC. | $14.68 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107373569 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.21 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105680399 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.62 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105581966 | CMS |
| Braeburn Inc. | $15.85 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125615201 | CMS |
| Exact Sciences Corporation | $17.92 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114546068 | CMS |
| Indivior Inc. | $20.15 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144556701 | CMS |
| Indivior Inc. | $26.90 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144556703 | CMS |
| Indivior Inc. | $34.78 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144556705 | CMS |
| Lilly USA, LLC | $19.43 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135716498 | CMS |
| Lilly USA, LLC | $22.65 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135703351 | CMS |
| Novo Nordisk Inc | $19.05 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100512783 | CMS |
| Novo Nordisk Inc | $21.96 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100462452 | CMS |
| Novo Nordisk Inc | $18.58 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100432141 | CMS |
| Novo Nordisk Inc | $22.92 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100600713 | CMS |
| Novo Nordisk Inc | $23.51 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100547780 | CMS |
| PFIZER INC. | $20.82 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131504219 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.